The Evolution Of Structural Heart Innovations

Structural heart innovations, like TAVR, have revolutionized treatment for patients who once had open-heart surgery as their only option. However, this progress introduces new engineering challenges, including the need for smaller delivery systems, improved sealing, and reliable, scalable manufacturing without compromising long-term durability or patient outcomes. The industry is now focused on designing thinner, more flexible, and stronger materials and applying TAVR learnings to less-served mitral and tricuspid therapies.

Bringing a new device from concept to commercialization demands specialized biomaterials and scalable processes that maintain quality from R&D to high-volume production. Customization is essential as new indications bring unique mechanical and biological demands, often requiring advanced textile architectures and surface treatments for better fit and sealing. As procedure volumes climb and indications broaden, deep materials expertise and strategic partnerships are critical to meet these expanding demands.

Discover how a partnership model helps overcome the challenges driving the next generation of structural heart devices. Download the article to read more.